US Cannabis Industry Posts First-Ever Revenue Decline in 2025

The Numbers Behind the Cannabis Revenue Decline

The headline figures tell a stark story. After more than a decade of unbroken growth that saw the US cannabis industry expand from a handful of medical-only state programs into a multibillion-dollar national marketplace, 2025 delivered the first contraction. Whitney Economics pegged total revenue between $29.1 billion and $29.6 billion, depending on methodology and which markets are included, down from $30.1 billion the prior year.

A 3.2% decline might sound modest in isolation, but context is everything. This is an industry that grew 30% or more annually for much of the past decade. Even during the challenging years of 2023 and 2024, when price compression began taking hold in major markets, national totals still managed to inch upward as new state programs launched and provided fresh demand.

In 2025, the new market openings were not enough to offset deterioration in established ones. Twenty-three states saw their cannabis revenues decline, meaning the contraction was not concentrated in a few troubled markets but spread across the majority of the country's legal cannabis landscape.

Oversupply: The Root Cause of the Cannabis Market Crisis

The single biggest driver of the revenue decline is oversupply, a problem that has been building for years and reached critical mass in 2025. Across essentially all mature cannabis markets, licensed producers have been growing far more cannabis than consumers are buying.

The oversupply problem has its roots in the early days of state legalization, when regulators issued large numbers of cultivation licenses to build out supply for new markets. In many states, the supply materialized faster than demand, creating a structural imbalance that has proven extremely difficult to correct.

California, the largest cannabis market in the country, offers perhaps the most dramatic example. The state's licensed cultivation capacity has far exceeded consumer demand for years, driving wholesale flower prices below the cost of production for many operators. Similar dynamics have played out in Oregon, Colorado, Michigan, and other mature markets.

The consequences of oversupply cascade through the entire value chain. When wholesale prices fall, cultivators see their margins squeezed or eliminated entirely. Processors and manufacturers who buy wholesale flower face their own margin pressure as they compete to sell finished products to retailers at ever-lower prices. And while consumers benefit from lower retail prices in the short term, the widespread business failures that result from unsustainable pricing ultimately reduce product diversity, quality investment, and market competition.

Price Compression and Declining Margins Across Cannabis Markets

Price compression has been the most visible symptom of oversupply. Wholesale cannabis flower prices in many markets have fallen 50-70% from their peaks, and in some cases have dropped below the cost of production. Even markets that once seemed insulated from price pressure, like Illinois and Massachusetts, have seen significant wholesale declines as supply has caught up to and exceeded demand.

For cannabis businesses, falling prices translate directly into shrinking margins. Many operators entered the industry with business plans built on wholesale prices of $2,000 or more per pound. When those prices drop to $500 or $300, the math simply stops working for operations with significant overhead in the form of facility costs, labor, compliance, and taxes.

The margin squeeze has been particularly brutal for cultivators and small operators who lack the scale efficiencies needed to remain profitable at low price points. Vertically integrated companies with their own retail outlets have fared somewhat better, since they capture margin at multiple points in the supply chain, but even these larger operations have felt the pressure.

Retail pricing has also declined in most markets, though not as sharply as wholesale. The gap between wholesale and retail price declines has been a point of contention in the industry, with cultivators arguing that retailers have maintained their margins by passing wholesale savings to consumers selectively rather than proportionally.

Over 4,000 Cannabis Businesses Gave Up Licenses

The human toll of the downturn is measured in closed businesses and lost jobs. Over the past 18 months, more than 4,000 cannabis businesses across the country have surrendered their licenses, choosing to exit the industry rather than continue operating at a loss.

These closures span every segment of the supply chain. Cultivation operations have been particularly hard hit, as they face the most direct impact of falling wholesale prices. But processing facilities, testing laboratories, distribution companies, and even retail dispensaries have been among the casualties.

The license surrenders represent an organic market correction that regulators have been reluctant to engineer through policy. While some states have considered production caps, cultivation moratoriums, or license limitations, most have allowed the market to self-correct through the harsh mechanism of business failure.

For the workers at these companies, the closures mean unemployment in a sector that often struggles to offer transferable credentials. Cannabis industry experience can be difficult to leverage in job searches due to the continued federal illegality and the lingering stigma around the plant, leaving displaced workers in a particularly challenging position.

The closures also disproportionately affect social equity licensees and small operators who entered the industry with limited capital reserves. These businesses, many of which were established to address the harms of cannabis prohibition on communities of color, often lack the financial runway to survive extended periods of below-cost pricing.

Bright Spots: Newer Cannabis Markets Growing Over 100%

Not every market shared in the decline. Newer cannabis programs in states including New York, Ohio, New Jersey, and Minnesota posted growth rates exceeding 100% as they continued the rapid expansion phase that characterizes newly opened markets.

New York, despite its well-documented regulatory challenges and ongoing struggles with the illicit market, has seen legal sales accelerate as additional dispensaries have opened and the state has worked to streamline its licensing process. The sheer size of the New York metro area population gives the market enormous potential that is still being unlocked.

Ohio's recreational market, which launched following voter approval, has benefited from strong consumer enthusiasm and a regulatory framework that allowed for relatively quick implementation. The state's population of nearly 12 million provides a substantial consumer base, and early sales figures have exceeded projections.

New Jersey has continued to build on its early momentum, with the market benefiting from its proximity to New York City consumers and a regulatory environment that has been more permissive regarding retail licensing than many neighboring states.

Minnesota's adult-use market, while still in its early stages, has shown strong initial performance. The state's approach to licensing and regulation drew on lessons learned from other states' experiences, helping to avoid some of the pitfalls that have hampered other new market launches.

These growth markets have provided some cushion against the broader national decline, and their continued expansion is one of the factors behind Whitney Economics' forecast that overall industry growth will resume in 2026.

The Role of the Unregulated Cannabis Market

The revenue decline cannot be fully understood without accounting for the unregulated cannabis market, which by most estimates remains larger than the legal market in many states. As legal cannabis prices have fallen, the price differential between regulated and unregulated products has narrowed in some markets, but in others, particularly those with high tax rates and burdensome regulatory costs, the illicit market continues to offer significantly lower prices.

High taxes on legal cannabis have been a persistent complaint from operators who argue that tax burdens of 25-40% or more make it impossible to compete with unregulated sellers who face no such costs. Some states, including California and Washington, have reduced cannabis tax rates in response to these concerns, but many others have maintained or even increased their tax take.

Regulatory compliance costs add another layer of expense that unregulated operators avoid. Testing requirements, seed-to-sale tracking systems, security mandates, and packaging regulations all add to the cost of doing business legally, further widening the price gap with the black market.

The persistence of the unregulated market means that the legal industry's revenue figures understate total cannabis consumption. Consumers are still buying and consuming cannabis at high rates, but a significant portion of that activity is occurring outside the tracked legal market.

Whitney Economics Forecasts Growth Will Resume in 2026

Despite the concerning 2025 numbers, Whitney Economics projects that the cannabis industry will return to growth in 2026. Several factors support this forecast.

First, the business closures and license surrenders of the past 18 months are beginning to reduce the supply glut. As uneconomical operators exit, the remaining businesses face less competition and may see wholesale prices stabilize or recover modestly.

Second, new market openings continue to add fresh demand. States that have recently launched or expanded their programs will contribute incremental revenue growth that did not exist in prior years.

Third, the federal regulatory environment is shifting in ways that could benefit the industry. Cannabis rescheduling, banking reform, and potential changes to the Section 280E tax treatment could reduce the operational burdens on legal cannabis companies, improving their competitive position relative to the unregulated market.

Fourth, the newer markets that grew over 100% in 2025 still have significant room for expansion as they add retail locations, build out their customer bases, and reach their mature-market potential.

However, the return to growth is unlikely to mean a return to the heady expansion rates of the industry's early years. The era of 30% annual growth appears to be over, replaced by a more mature market dynamic where growth rates may resemble those of other consumer packaged goods categories, in the low to mid single digits.

What the Cannabis Revenue Decline Means for the Industry's Future

The 2025 revenue decline marks a transition point for the US cannabis industry. The era of growth-at-all-costs is giving way to a period where profitability, operational efficiency, and sustainable business models matter more than top-line expansion.

For operators who survive the current shakeout, the competitive landscape on the other side may actually be more favorable. Fewer competitors, stabilized pricing, and a consumer base that continues to grow as stigma recedes and new markets open could create conditions for healthy, profitable businesses.

For investors, the decline serves as a reality check on the growth assumptions that fueled cannabis stock valuations and private market fundraising in the industry's boom years. The survivors of this contraction will likely be the companies that prioritized cash flow management, operational discipline, and realistic market positioning over aggressive expansion funded by dilutive capital.

For regulators and policymakers, the data presents a challenge. The promise of cannabis tax revenue has been a major selling point for legalization, and declining sales in mature markets mean declining tax collections at a time when many state and local governments have already committed those funds to programs and services.

The 2025 numbers are a wake-up call, but they need not be a death knell. Industries go through cycles of expansion and contraction, and the cannabis sector's first downturn, while painful, may ultimately prove to be a necessary step in the industry's maturation from a speculative gold rush into a stable, regulated consumer products market.

Looking for a dispensary near you? Browse Budpedia's cannabis dispensary directory — verified shops across every legal state.